The briefing
Chad R. Ritch, MD, discusses how PSMA-PET informs staging and treatment planning in prostate cancer. He also addresses its use in recurrence workups and interpreting equivocal findings.
Original headline
How PSMA-PET shapes staging and recurrence workup in prostate cancer